The story has been updated to include comments from NeoGenomics' conference call on Wednesday.

NEW YORK (GenomeWeb) – NeoGenomics on Wednesday said that its fourth quarter revenues more than doubled year over year as clinical genetic test volumes also shot up, driven by the inclusion of Clarient's results.

NeoGenomics acquired Clarient from GE Healthcare Life Sciences at the end of 2015.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.